Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
Home arrow Investors arrow Annual Reports and Proxy Materials

Annual Reports and Proxy Materials

Transcept in the News

03/09/10
Transcept Pharmaceuticals to Report Fourth Quarter and Full Year 2009 Results and Host Conference Call on March 23, 2010

02/22/10
Transcept Pharmaceuticals Provides Update on Intermezzo(R) Regulatory Review


PDF 2008 Form 10-K
PDF Proxy Card Front
PDF Proxy Card Back
PDF 2009 Proxy
PDF Driving Instructions to Annual Meeting, June 3, 2009

 
Copyright © 2010  |